PATENT CLAIM ANALYSIS

Application Number: 15773466
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
A pharmaceutical composition can be provide for treating or preventing heart failure. Additionally, siRNA and a vector expressing said siRNA can be provided that can be used in the pharmaceutical composition for treating or preventing heart failure. For example, a pharmaceutical composition can be provided for treating or preventing heart failure that contains a DNA sequence encoding RNA containing a sense strand sequence of consecutive 18 to 29 nucleotides from angiopoietin-like protein 2 (ANGPTL2) mRNA or the alternative splicing type RNA thereof and an antisense strand sequence complementary to the sense strand sequence under control of a promoter, and a pharmaceutically acceptable carrier.

Claim (Index 44):
The method of  claim 42 , further comprising administering the pharmaceutical composition according to  claim 28  to a patient whose expression level of angiopoietin-like protein 2 (ANGPTL2) in the blood of the coronary sinus (CS) is higher than the expression level in the blood of the aortic root (Ao).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.7619
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14342867', '12811306', '13702033', '12096216', '13389236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7786697036168629
- 35 USC 102 Novelty (BERT): 0.5286270248911162
- Combined Prediction Score: 0.7536654357442882
- Mean Citation Score: 307.718864
- Max Citation Score: 339.27847
- Similarity Product: 191.1704103626884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test